Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer

BMC Cancer

Kuo Zhang¹  Rongxue Peng¹  Chengming Sun²  Xin Yang²  Caiji Zhang² 

[1] 0000 0004 0447 1045, grid.414350.7, National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology, 100730, Beijing, People’s Republic of China;grid.440323.2, Department of Clinical Lab, Yantai Yuhuangding Hospital, 20 Yudong Road, 264000, Yantai, Shandong Province, People’s Republic of China;

关键词: PIK3CA;    TP53;    ESR1;    cfDNA;    Mutation;    Breast cancer;    Single nucleotide variation;    Copy number variation;   

DOI  :  10.1186/s12885-019-5698-x

来源: publisher

【 摘 要 】

BackgroundGene variants are dependable and sensitive biomarkers for target-specific therapies in breast cancer (BC). However, detection of mutations within tissues has many limitations. Plasma circulating free DNA (cfDNA) has been reported in many studies as an alternative tool for detection of mutations. But the diagnostic accuracy of cfDNA for most mutations in BC needs to be reviewed. This study was designed to perform comparative assessment of the diagnostic performance of cfDNA and DNA extracted from tissues for detection of single nucleotide variants (SNV) and copy number variants (CNV).MethodsTrue-positive (TP), false-positive (FP), false-negative (FN), and true-negative (TN) values were extracted from each selected study. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were calculated. Subgroup analysis and single study omitted analysis were performed to quantify and explain the study heterogeneity.ResultsTwenty eligible studies that involved 1055 cases were included in this meta-analysis. SNV studies in early breast cancer (EBC) subgroup are not suitable for meta-analysis owing to high heterogeneity. However, in advanced breast cancer (ABC) subgroup, the pooled sensitivity and specificity of detection of SNVs were 0.78 (0.71–0.84) and 0.92 (0.87–0.95), respectively. The summary receiver operative curve (SROC) exhibited an area under the curve (AUC) of 0.91(0.88–0.93). The pooled results of studies involving subgroups of PIK3CA, TP53, and ESR1 indicate that the diagnostic value of different genes is different, such as AUC for PIK3CA and TP53 were reported to be 0.96 (0.94–0.98) and 0.94 (0.91–0.95), respectively, and ESR1 had the lowest diagnostic value of 0.80 (0.76–0.83). Owing to the low sensitivity and AUC in the cases of CNV, there is no value for cfDNA-based detection of CNV based on insufficient amount of CNV data.ConclusionThis meta-analysis suggests that the detection of gene mutations in cfDNA have adequate diagnostic accuracy and can be used as an alternative to the tumor tissue for detection of SNV but not for CNV in BC yet.

【 授权许可】

CC BY